Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man

References

• Agoram, B , Woltosz, WS , and Bolger, MB , 2001. Predicting the impact of physiological and biochemical processes on oral drug bioavailability , Advances in Drug Delivery Reviews 50 (Suppl. 1) (2001), pp. S41–S67.
   PubMed Web of Science ®Google Scholar
• Antinori, A , Zaccarelli, M , Cingolani, A , Forbici, F , Rizzo, MG , Trotta, MP , Di Giambenedetto, S , Narciso, P , Ammassari, A , Girardi, E , et al., 2002. Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure , AIDS Research and Human Retroviruses 18 (12) (2002), pp. 835–838.
   PubMed Web of Science ®Google Scholar
• Boxenbaum, H , 1980. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: Extrapolation of data to benzodiazepines and phenytoin , Journal of Pharmacokinetics and Biopharmaceutics 8 (2) (1980), pp. 165–176.
   PubMedGoogle Scholar
• Brown, RP , Delp, MD , Lindstedt, SL , Rhomberg, LR , and Beliles, RP , 1997. Physiological parameter values for physiologically based pharmacokinetic models , Toxicology and Industrial Health 13 (4) (1997), pp. 407–484.
   PubMed Web of Science ®Google Scholar
• Carr, A , and Cooper, DA , 2000. Adverse effects of antiretroviral therapy , Lancet 356 (9239) (2000), pp. 1423–1430.
   PubMed Web of Science ®Google Scholar
• Corbau, R , Allan, G , Burt, C , Fishburn, L , Irving, S , Knoechel, T , Macdonald, G , Martin, A , Mowbray, C , Mori, J , et al., 2007. "UK-453,061: A non-nucleoside reverse transcriptase inhibitor for the treatment of drug-resistant HIV infections.". In: Paper presented at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) . Chicago, IL, USA. 2007, 2007.
   Google Scholar
• Davis, J , Jenkins, T , Asken, E , Stafford, H , Hackman, F , and Weissgerber, G , 2007. Pharmacokinetics of single and multiple oral doses of UK-453,061, a novel NNRTi, in healthy male subjects . Presented at Paper presented at the 4th IAS Conference on HIV Pathogenesis. Sydney, 2007.
   Google Scholar
• De Buck, SS , Sinha, VK , Fenu, LA , Nijsen, M , Mackie, C , and Gilissen, RAH , 2007. Prediction of human pharmacokinetics using physiologically based modeling: A retrospective analysis of 26 clinically tested drugs , Drug Metabolism and Disposition 35 (2007), pp. 1766–1780.
   PubMed Web of Science ®Google Scholar
• Eagling, VA , Back, DJ , and Barry, MG , 1997. Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir , British Journal of Clinical Pharmacology 44 (2) (1997), pp. 190–194.
   PubMed Web of Science ®Google Scholar
• Fichtenbaum, CJ , Gerber, JG , Rosenkranz, SL , Segal, Y , Aberg, JA , Blaschke, T , Alston, B , Fang, F , Kosel, B , and Aweeka, F , 2002. Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047 , AIDS 16 (4) (2002), pp. 569–577.
   PubMed Web of Science ®Google Scholar
• Gardner, IB , Walker, DK , Lennard, MS , Smith, DA , and Tucker, GT , 1995. Comparison of the disposition of two novel combined thromboxane synthase inhibitors/thromboxane A2 receptor antagonists in the isolated perfused rat liver , Xenobiotica 25 (2) (1995), pp. 185–197.
   PubMed Web of Science ®Google Scholar
• Gobry, VBG , Carrupt, P-A , Testa, B , and Girault, HH , 2000. Physicohcemical characterization of sildenafil: Ionization, lipophilicity behaviour, and ionic-partition diagram studied by two-phase titration and electrochemistry , Helvetica Chimica Acta 83 (2000), pp. 1465–1474.
   Web of Science ®Google Scholar
• Harris, M , and Montaner, JS , 2000. Clinical uses of non-nucleoside reverse transcriptase inhibitors , Reviews in Medical Virology 10 (4) (2000), pp. 217–229.
   PubMed Web of Science ®Google Scholar
• Ito, K , and Houston, JB , 2004. Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes , Pharmaceutical Research 21 (5) (2004), pp. 785–792.
   PubMed Web of Science ®Google Scholar
• Ito, K , and Houston, JB , 2005. Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches , Pharmaceutical Research 22 (1) (2005), pp. 103–112.
   PubMed Web of Science ®Google Scholar
• Jones, HM , Parrott, N , Jorga, K , and Lave, T , 2006. A novel strategy for physiologically based predictions of human pharmacokinetics , Clinical Pharmacokinetics 45 (5) (2006), pp. 511–542.
   PubMed Web of Science ®Google Scholar
• Poulin, P , Schoenlein, K , and Theil, FP , 2001. Prediction of adipose tissue:Plasma partition coefficients for structurally unrelated drugs , Journal of Pharmaceutical Sciences 90 (4) (2001), pp. 436–447.
   PubMed Web of Science ®Google Scholar
• Poulin, P , and Theil, FP , 2000. A priori prediction of tissue–plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery , Journal of Pharmaceutical Sciences 89 (1) (2000), pp. 16–35.
   PubMed Web of Science ®Google Scholar
• Robbins, GK , De Gruttola, V , Shafer, RW , Smeaton, LM , Snyder, SW , Pettinelli, C , Dube, MP , Fischl, MA , Pollard, RB , Delapenha, R , et al., 2003. Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection , New England Journal of Medicine 349 (24) (2003), pp. 2293–2303.
   PubMed Web of Science ®Google Scholar
• Rodgers, T , Leahy, D , and Rowland, M , 2005a. Physiologically based pharmacokinetic modeling 1: Predicting the tissue distribution of moderate-to-strong bases , Journal of Pharmaceutical Sciences 94 (6) (2005a), pp. 1259–1276.
   PubMed Web of Science ®Google Scholar
• Rodgers, T , Leahy, D , and Rowland, M , 2005b. Tissue distribution of basic drugs: Accounting for enantiomeric, compound and regional differences amongst beta-blocking drugs in rat , Journal of Pharmaceutical Sciences 94 (6) (2005b), pp. 1237–1248.
   PubMed Web of Science ®Google Scholar
• Rodgers, T , and Rowland, M , 2006. Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions , Journal of Pharmaceutical Sciences 95 (6) (2006), pp. 1238–1257.
   PubMed Web of Science ®Google Scholar
• Smith, PF , DiCenzo, R , and Morse, GD , 2001. Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors , Clinical Pharmacokinetics 40 (12) (2001), pp. 893–905.
   PubMed Web of Science ®Google Scholar
• Stopher, D , and McClean, S , 1990. An improved method for the determination of distribution coefficients , Journal of Pharmacy and Pharmacology 42 (2) (1990), p. 144.
   PubMed Web of Science ®Google Scholar
• Torti, C , Maggiolo, F , Patroni, A , Suter, F , Ladisa, N , Paraninfo, G , Pierotti, P , Orani, AM , Minoli, L , Arici, C , et al., 2005. Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: Results from the Italian MASTER Cohort , Journal of Antimicrobial Chemotherapy 56 (1) (2005), pp. 190–195.
   PubMed Web of Science ®Google Scholar
• Turpin, JA , 2003. The next generation of HIV/AIDS drugs: Novel and developmental antiHIV drugs and targets , Expert Review of Anti-Infective Therapy 1 (1) (2003), pp. 97–128.
   PubMedGoogle Scholar
• UNAIDS, 2006. AIDS epidemic update special report on HIV/AIDS , (2006), ISBN: 929 173542 6.
   Google Scholar
• Yu, LX , and Amidon, GL , 1999. A compartmental absorption and transit model for estimating oral drug absorption , International Journal of Pharmaceutics 186 (2) (1999), pp. 119–125.
   PubMed Web of Science ®Google Scholar